| Literature DB >> 31192115 |
Marta Sabater-Martos1,2, Irene Katharina Sigmund1,3, Constantinos Loizou1, Martin McNally1.
Abstract
Introduction: Calcaneal osteomyelitis is an uncommon and challenging condition. In this systematic review we aim to analyse the outcomes from concomitant use of bone debridement and soft tissue management for patients diagnosed with calcaneal osteomyelitis. Materials &Entities:
Keywords: antimicrobial carrier; calcaneal osteomyelitis; infection.; muscle flap; outcome; systematic review; treatment
Year: 2019 PMID: 31192115 PMCID: PMC6536802 DOI: 10.7150/jbji.34452
Source DB: PubMed Journal: J Bone Jt Infect ISSN: 2206-3552
Figure 11a: Coronal MRI showing central abscess with sinus extending to the medial side. There is no subperiosteal extension of the abscess. This infection followed internal fixation of a closed, complex calcaneal fracture. 1b: Sagittal MRI showing the classical 'corona' sign of osteomyelitis.
Figure 22a: Plantar ulceration over calcaneal osteomyelitis in a patient with paraplegia after spinal cord injury. 2b: CT Scan showing the bone destruction deep to the ulcer.
Figure 3PRISMA flow diagram.
Systematic review of studies describing bone treatment for calcaneal osteomyelitis. Treatment
| Reference | Patients (no.) | Diabetes (no.) | Bone treatment | Antibiotic carrier | Soft tissue closure | Postoperative antibiotic |
|---|---|---|---|---|---|---|
| Bollinger et al. 2002 | 22 | 9 | PC | None | Primary closure | NA |
| Brooks et al. 2004 | 17 (20 feet) | 13 | 15 PC and 5 TC | None | Primary closure or NPWT | 6 weeks culture specific |
| Fisher et al. 2010 | 2 | 2 | PC with Hurricane approach | None | Primary closure | NA |
| Schade 2012 | 100 (16 papers) | NA | 76 PC and 28 TC | NA | NA | NA |
| Oliver et al. 2015 | 42 | Cohort 1: 20/25 | Cohort 1: <50% PCCohort 2: >50% PC | none | Delayed primary closure | NA |
| Babiak et al. 2016 | 32 | NA | Bone preserving techniques vs PC and TC | CGS | NA | 2 weeks empirical iv or oral + 4 weeks culture specific |
| Drampalos et al. 2017 | 12 | 12 | Silo technique | Gentamicin loaded bioceramic | Primary closure or NPWT | Empiric gentamicin + teicoplanin and modified accordingly for 6 to 12 weeks |
| Fraccalvieri et al. 2012 | 7 | 2 | PC | None | Integra dermal regeneration template + NPWT for 14 days+ skin graft | After both procedures protocol antibiotic, when cultures available a specific antibiotic |
| Gohds et al. 2012 | 3 | 0 | Radical debridement with cortical shell preservation | None | NPWT + gracilis free flap | Culture specific antibiotic |
| Goudie et al. 2012 | 21 | 21 | PC | None | NPWT +1) split thickness graft, 2) allogenic bilayered skin subsitute or3) rhPDGF/ORC/coll. | NA |
| Paola et al. 2016 | 18 | 1 | PC | None | External frame + NPWT + dermal substitute + split thickness skin graft | 2 weeks iv followed by 4 weeks oral |
| Akkurt et al. 2017 | 23 | 23 | MRI guided debridement | None | External frame | NA |
Systematic review of studies describing bone treatment for calcaneal osteomyelitis. Results and follow up.
| Reference | Infection Recurrence | Amputation | Functional outcome | Follow up (months) |
|---|---|---|---|---|
| Bollinger et al. 2002 | 0 | 0 | NA | 27 (2-80) |
| Brooks et al. 2004 | 35% | 6 (30%) | NA | NA |
| Fisher et al. 2010 | NA | 0 | NA | NA |
| Schade 2012 | NA | NA | 85% maintain or increase ambulatory status | 33 |
| Oliver et al. 2015 | NA | Cohort 1: 7 (28%) | LEFS | Cohort 1: 43Cohort 2: 38 |
| Babiak et al. 2016 | Bone preserving: 23.5% PC or TC: 11.8% | 4 (12.5%) | Walking abilityBone preserving:100%PC or TC: 93.33% | Minimal of 24 months |
| Drampalos et al. 2017 | 0 | 0 | 6/8 maintain ambulatory status | 4 |
| Fraccalvieri et al. 2012 | 0 | 0 | All patients maintain preoperative mobility | 22 (6-36) |
| Gohds et al. 2012 | 0 | 0 | All patients return to ambulatory status | NA |
| Goudie et al. 2012 | 24% | 4 (24%) | 57% independent ambulation | 24 |
| Paola et al. 2016 | 0 | 0 | NA | 7.5 |
| Akkurt et al. 2017 | 5 (22%) | 2 (8.7%) | 78% were able to ambulate | 4.5 |
*Note. NA: not available, Cohort 1(patients who received a <50%PC, cohort 2 (patients who received >50%PC) PC: partial calcanectomy, TC: total calcanectomy, CGS: collagen gentamicin sponge, NPWT: negative pressure wound therapy, rhPDGF/ORC/coll: recombinant platelet-derived growth factor/oxidised regenerated cellulose/bovine collagen, LEFS: lower extremity functional scale
Below middle line studies describing both bone and soft tissue treatment
Systematic review of studies describing soft tissue treatment for calcaneal osteomyelitis. Treatment
| Reference | Infection Recurrence | Amputation | Functional outcome | Follow up (months) |
|---|---|---|---|---|
| Al-Qattan 2001 | 0 | 0 | NA | 36 |
| Yildirim et al. 2003 | 1 (11%) | 0 | 8/9 returned to presurgical ambulatory status | 22 (15- 27) |
| Chen et al. 2005 | 0 | 0 | 100% returned to presurgical ambulatory status | (6-12) |
| Xu et al. 2009 | 0 | 0 | AOFAS score after 6 months: 76 | 34 (6-72) |
| Boffeli et al. 2013 | 0 | 0 | 100% returned to presurgical ambulatory status | NA |
| Wang et al. 2014 | 0 | 0 | NA | 12(6-22) |
| Fraccalvieri et al. 2012 | 0 | 0 | All patients maintain preoperative mobility | 22 (6-36) |
| Gohds et al. 2012 | 0 | 0 | All patients return to ambulatory status | NA |
| Goudie et al. 2012 | 24% | 4 (24%) | 57% independent ambulation | 24 |
| Paola et al. 2016 | 0 | 0 | NA | 7.5 |
| Akkurt et al. 2017 | 5 (22%) | 2 (8.7%) | 78% were able to ambulate | 4.5 |
Systematic review of studies describing soft tissue treatment for calcaneal osteomyelitis. Results and follow up.
| Reference | Patients (no.) | Diabetes (no.) | Bone treatment | Antibiotic carrier | Soft tissue closure | Postoperative antibiotic |
|---|---|---|---|---|---|---|
| Al-Qattan 2001 | 4 | 0 | Debridement | None | Abductor digiti minimi | NA |
| Yildirim et al. 2003 | 9 | 6 | PC with cortical shell preservation | None | Sural or saphenous neurocutaneous flap | 3-4 weeks iv followed by 2-3 weeks oral treatment |
| Chen et al. 2005 | 11 | 11 | Debridement | None | Sural fasciomusculocutaneous flap | Adjusted according culture results |
| Xu et al. 2009 | 13 | 0 | Removal of sequestra and resection od scarred and infected bone | None | Free serratus muscle flap + skin graft | Iv treatment based on culture results |
| Boffeli et al. 2013 | 3 | 0 | PC | None | Rotational flap closure | NA |
| Wang et al. 2014 | 5 | 0 | Debridement | None | Sural flap with adiponeurofascial portion filling the bone cavity and neurofasciocutaneous portion covering the wound | 4 weeks iv + 2 weeks oral treatment adapted to cultures |
| Fraccalvieri et al. 2012 | 7 | 2 | PC | None | Integra dermal regeneration template + NPWT for 14 days+ skin graft | After both procedures protocol antibiotic, when cultures available a specific antibiotic |
| Gohds et al. 2012 | 3 | 0 | Radical debridement with cortical shell preservation | None | NPWT + gracilis free flap | Culture specific antibiotic |
| Goudie et al. 2012 | 21 | 21 | PC | None | NPWT +1) split thickness graft, 2) allogenic bilayered skin substitute or3) rhPDGF/ORC/coll. | NA |
| Paola et al. 2016 | 18 | 1 | PC | None | External frame + NPWT + dermal substitute + split thickness skin graft | 2 weeks iv followed by 4 weeks oral |
| Akkurt et al. 2017 | 23 | 23 | MRI guided debridement | None | External frame | NA |
*Note. NA: not available, PC: partial calcanectomy, NPWT: negative pressure wound therapy, rhPDGF/ORC/coll: recombinant platelet-derived growth factor/oxidised regenerated cellulose/bovine collagen, AOFAS: American Orthopaedic Foot & Ankle Society
Below middle line studies describing both bone and soft tissue treatment